{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:57:06Z","timestamp":1781927826678,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Croatian Ministry of Science, Education and Sports","award":["021-0212432-2033"],"award-info":[{"award-number":["021-0212432-2033"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.vaccine.2010.04.111","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T06:10:41Z","timestamp":1274076641000},"page":"5497-5502","source":"Crossref","is-referenced-by-count":11,"title":["Robustness testing of live attenuated rubella vaccine potency assay using fractional factorial design of experiments"],"prefix":"10.1016","volume":"28","author":[{"given":"Leonida","family":"Kutle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nediljko","family":"Pavlovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Doroti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Zadro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Kapusti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Halassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.04.111_bib1","unstructured":"European Directorate for Quality of Medicines. Rubella virus (live) (04\/2009:0162). In: European Pharmacopoeia. Supplement 6.1 to 6th ed. 2007. p. 3358\u20133359."},{"key":"10.1016\/j.vaccine.2010.04.111_bib2","unstructured":"The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of analytical procedures: Text and Methodology Q2(R1). http:\/\/www.emea.europa.eu\/htms\/human\/ich\/background.htm."},{"key":"10.1016\/j.vaccine.2010.04.111_bib3","unstructured":"United States Pharmacopeia. <1225> Validation on compendial procedures. In: U.S. Pharmacopeia 31 \u2013 NF 26, vol. 1; 2008. p. 683\u2013687."},{"key":"10.1016\/j.vaccine.2010.04.111_bib4","unstructured":"World Health Organisation. Validation of analytical assays. In: A WHO Guide to Good Manufacturing Practice (GMP) Requirements WHO\/VSQ\/97.02; 1997. p. 69."},{"key":"10.1016\/j.vaccine.2010.04.111_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0731-7085(00)00529-X","article-title":"Guidance for robustness\/ruggedness tests in method validation","volume":"24","author":"Vander Heyden","year":"2001","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.vaccine.2010.04.111_bib6","series-title":"Design of experiments, principles and applications","author":"Eriksson","year":"2000"},{"key":"10.1016\/j.vaccine.2010.04.111_bib7","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jchromb.2008.09.030","article-title":"Key aspects of analytical method validation and linearity evaluation","volume":"877","author":"Araujo","year":"2009","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.vaccine.2010.04.111_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.chroma.2007.02.086","article-title":"Ruggedness and robustness testing","volume":"1158","author":"Dejaegher","year":"2007","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.vaccine.2010.04.111_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.aca.2006.11.077","article-title":"Comparison of Plackett\u2013Burman and supersaturated designs in robustness testing","volume":"595","author":"Dejaegher","year":"2007","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.vaccine.2010.04.111_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.aca.2004.12.071","article-title":"Robustness tests on the United States pharmacopoeia XXVI HPLC assay for ginsenosides in Asian and American ginseng using an experimental design","volume":"536","author":"Li","year":"2005","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.vaccine.2010.04.111_bib11","first-page":"25","article-title":"Validation of biological assays","volume":"107","author":"Schofield","year":"2002","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2010.04.111_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/biol.1998.0134","article-title":"Virus assay methods: accuracy and validation","volume":"26","author":"Darling","year":"1998","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2010.04.111_bib13","unstructured":"National Institute of Standards and Technology. Improve. In: Engineering Statistical Handbook. http:\/\/www.itl.nist.gov\/div898\/handbook\/index.htm."},{"key":"10.1016\/j.vaccine.2010.04.111_bib14","unstructured":"World Health Organisation. Requirements for measles, mumps and rubella vaccines and combined vaccine (live). In. WHO Technical Report Series 840. Annex 3. 1994; p. 100\u2013201."},{"key":"10.1016\/j.vaccine.2010.04.111_bib15","unstructured":"World Health Organisation: Live rubella virus vaccine. In: Manual of Laboratory Merhods for Testing Vaccines used in the WHO Expanded Programme on Immunization WHO\/VSQ\/97.04; 1997. p. 87\u201390."},{"key":"10.1016\/j.vaccine.2010.04.111_bib16","first-page":"183","article-title":"Evaluation and validation of potency testing method for live rubella virus vaccine","volume":"9","author":"Wang","year":"2001","journal-title":"J Food Drug Anal"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T05:27:07Z","timestamp":1544506027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10006626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":16,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0264410X10006626"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.111","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}